Project

A Phase 3 Randomized, Double-Blind Study of NivolumabMonotherapy or NivolumabCombined with Ipilimumab vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse

Completed · 2020 until 2024

Rothermundt Christian, Wittwer Yvonne, Quinter Janine